Helena Laboratories, Corp. recalls V8 Immunodisplacement Kit REF 1803
- Recall date
- April 6, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1244-2022
- FDA classification
- Class II
- Brand / firm
- Helena Laboratories, Corp.
- Sold / distributed
- U.S.: FL, MO, OH, and TX O.U.S.: Canada, Uruguay, and Vietnam,
Why it was recalled
Due to microbial growth causing interference with interpretation.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
V8 Immunodisplacement Kit REF 1803
Get recall alerts
Free email alert whenever Helena Laboratories, Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Helena Laboratories, Corp.